Cyberonics, Inc.: Warming Up or Cooling Off? Nov 21, 2009
Immucor, Inc.(Nasdaq: BLUD). Stereotaxis, Inc.(Nasdaq: STXS). (MSNBC -- Business)
Immucor net income rises Oct 2, 2009
Despite the economy, we continue to generate revenue, earnings and cash flow growth due to the needs-based aspect of our business and our focus on automation that improves blood bank operations, said Dr. Gioacchino De Chirico, Immucor president and CEO, in an earnings release. Most Read Stories. (Atlanta Business Chronicle, GA)
Earnings Roundup: Global Payments, Immucor Oct 2, 2009
Earnings roundup: Global Payments 1Q profit rises, Immucor earnings grow 7 percent in 1Q ... (AP) Immucor Inc., which makes products used in blood transfusions, said its profit grew 7 percent in the fiscal first quarter as sales in all of its product groups improved. (ABC News -- Wire)
Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP Sep 23, 2009
Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer , LLP ... Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of securities of Immucor, Inc. (Nasdaq: ) ("Immucor" or the "Company") between October 19, 2005 and April 23,... (PR Newswire)
Immunocor Expands Stock Buyback Authorization Aug 19, 2009
Immucor Inc., which makes products used in blood transfusions, said Tuesday that its board has authorized the company to repurchase an additional 2 million shares of its common stock under its current buyback program. Including the new authorization, Norcross, Ga. (ABC News -- Wire)
Immucor Announces 2 Million Share Increase to Stock Repurchase Program Aug 19, 2009
Aug. 18 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: ), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that its board of directors has authorized an additional 2 million common shares for repurchase under its current stock repurchase program ... "Share repurchase is a good use of our free cash flow," stated Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer ... "We believe in the long-term potential... (PR Newswire)
Some companies left behind in bull's dust Aug 12, 2009
Real solutions for your real estate needs. Choose from the selections below. (USA Today -- Money)
> Immucor ends fiscal 09 with $76M profit Jul 24, 2009
Immucor ends fiscal 09 with $76M profit - Atlanta Business Chronicle ... Immucor ends fiscal 09 with $76M profit ... "For fiscal 2009, we achieved record revenue, earnings and cash flow from operations," said Gioacchino De Chirico, Immucor president and CEO, in an earnings statement. (Atlanta Business Chronicle, GA)
Immucor names new COO Jul 17, 2009
"His experience and results-oriented track record will enhance our efforts to improve transfusion medicine through automation, said Gioacchino De Chirico, Immucor president and CEO, in a news release. Our commitment to improving blood bank operations and patient safety benefits our customers, employees and shareholders." ... -based Immucor (NASDAQ: BLUD) earlier this week announced it in response to threats from federal regulators to revoke its biologics license after discovering deficiencies in... (Atlanta Business Chronicle, GA)
Immucor responds to FDA Jul 14, 2009
The statement reiterates Immucor s commitment make corrections to address the FDA's noted deficiencies, Immucor said. The FDA, in an administrative action based on an early January inspection, to revoke Immucor s biologics license with respect to its Reagent Red Blood Cells and Anti-E (Monoclonal) Blood Grouping Reagent product, the company said in a statement ... Immucor (NASDAQ: BLUD) said in June it spent more than $2 million during fiscal 2009 on improving quality systems and it expects to... (Atlanta Business Chronicle, GA)
FDA could pull Immucor reagent license Jun 27, 2009
FDA threatens to revoke Immucor's reagents license - Atlanta Business Chronicle ... FDA threatens to revoke Immucor's reagents license ... The news sent Immucor stock into a swoon. (Atlanta Business Chronicle, GA)
Stocks Finish Mostly Lower Jun 27, 2009
Immucor () says the FDA issued a notice of intent to revoke the company's biologics license with respect to its Reagent Red Blood Cells and Anti-E (Monoclonal) Blood Grouping Reagent product. Notes the FDA has not ordered the recall of any of the company's products. (BusinessWeek)
DOJ subpoenas Immucor Apr 30, 2009
-based Immucor (NASDAQ: BLUD) said it will cooperate fully with the investigation. In 2007, the company to the related to charges of improper payments Immucor's Italian subsidiary allegedly made to an Italian physician ... Immucor s in the second quarter of 2009. (Atlanta Business Chronicle, GA)
Analysts Mull Whether Earnings Bar is Low Enough Apr 8, 2009
Ahead of Alcoa's results, commercial glass provider Apogee Enterprises Inc. (APOG) and blood bank automator Immucor Inc. (BLUDE) are both scheduled to release earnings after Monday's close. "Earnings expectations for most companies have been dramatically lowered over the last 90 days, a fact recognized in the drop in stock prices over the same period. The question is whether analysts have lowered expectations enough and whether companies meet or top the lowered performance bar," Dickson said. (SmartMoney)
Stocks Pull Back In Lower Volume Apr 8, 2009
eIBD Investor's Business Daily Digital Edition. Access recent eIBD issues easily. (Investors Business Daily)
Applied Materials, General Motors, Humana, Immucor: U.S. Equity Preview Apr 7, 2009
Applied Materials, GM, Humana, Immucor: U.S. Equity Preview - Bloomberg ... Applied Materials, GM, Humana, Immucor: U.S. Equity Preview. (Bloomberg -- US)
Georgia Top Stocks Feb 8, 2009
place_ad_here("top_slot1"). Select stock category from this list. (Atlanta Journal-Constitution -- Home & Garden)
